Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
复制标题
基于放射组学的局部晚期直肠癌新辅助治疗无反应的治疗前预测。
DOI:
10.1245/s10434-019-07300-3
复制
发表时间:
2019-06-01
影响因子:
3.7
通讯作者:
Tian, Jie
中科院分区:
文献类型:
--
作者:
Zhou, Xuezhi;Yi, Yongju;Tian, Jie
ObjectiveThe aim of this study was to investigate whether pretherapeutic, multiparametric magnetic resonance imaging (MRI) radiomic features can be used for predicting non-response to neoadjuvant therapy in patients with locally advanced rectal cancer (LARC).MethodsWe retrospectively enrolled 425 patients with LARC [allocated in a 3:1 ratio to a primary (n=318) or validation (n=107) cohort] who received neoadjuvant therapy before surgery. All patients underwent T1-weighted, T2-weighted, diffusion-weighted, and contrast-enhanced T1-weighted MRI scans before receiving neoadjuvant therapy. We extracted 2424 radiomic features from the pretherapeutic, multiparametric MR images of each patient. The Wilcoxon rank-sum test, Spearman correlation analysis, and least absolute shrinkage and selection operator regression were successively performed for feature selection, whereupon a multiparametric MRI-based radiomic model was established by means of multivariate logistic regression analysis. This feature selection and multivariate logistic regression analysis was also performed on all single-modality MRI data to establish four single-modality radiomic models. The performance of the five radiomic models was evaluated by receiver operating characteristic (ROC) curve analysis in both cohorts.ResultsThe multiparametric, MRI-based radiomic model based on 16 features showed good predictive performance in both the primary (p